CO psychedelic ballot sigs submitted; Congress pushes psilocybin review & hemp as plastic alternative; LA gov signs marijuana employment protections

Subscribe to receive Marijuana Moment’s newsletter in your inbox every weekday morning. It’s the best way to make sure you know which cannabis stories are shaping the day.

Your support makes Marijuana Moment possible…

Your good deed for the day: donate to an independent publisher like Marijuana Moment and ensure that as many voters as possible have access to the most in-depth cannabis reporting out there.

Support our work at


The House Appropriations Committee is calling for a review of psilocybin policies, pushing for hemp as an alternative to Chinese plastics and advocating that researchers be able to study marijuana from dispensaries. The panel also defeated an amendment to scale back protections for TV and radio stations that run cannabis ads.

The House Appropriations Committee will vote on an amendment to protect all state, territory and tribal cannabis laws from federal interference on Tuesday, Marijuana Moment has learned.

White House Office of National Drug Control Policy Director Rahul Gupta—informally known as the “drug czar”—acknowledged that “cannabis can be efficacious” in treating chronic pain and that current marijuana laws “have not worked.”

Colorado activists turned in what they say are more than enough signatures to put a measure to legalize psychedelics and create a system of licensed psilocybin “healing centers” on the November ballot.

Louisiana Gov. John Bel Edwards (D) signed a bill to protect most state workers from being subject to “negative employment consequences” due to legal medical cannabis use.

The California State Fair unveiled the winners of its first-ever state-sanctioned marijuana competition, awarding 60 trophies and medals to businesses whose products were judged based on lab testing for quality and cannabinoid profiles.


Customs and Border Protection settled a Freedom of Information Act lawsuit over internal documents about its policy on Canadian cannabis industry participants’ admissibility to the country.

The House of Representatives passed a resolution calling for the release of American basketball player Brittney Griner, who is being detained in Russia after allegedly being caught with cannabis vapes at an airport.

Rep. Eleanor Holmes Norton (D-DC) sent a press release touting the lack of a rider blocking Washington, D.C. from legalizing recreational marijuana sales in a spending bill that cleared a House committee.

Rep. Larry Bucshon (R-IN) said he opposes “broad legalization” of marijuana and that there’s “very few” medical conditions that cannabis can help but that it should perhaps be rescheduled to Schedule II to make it easier to research.


California lawmakers are considering budget legislation that would eliminate the marijuana cultivation tax and maintain a current 15 percent excise tax for three years.

A Pennsylvania senator said he thinks the state will legalize marijuana by 2024.

An Alaska senator said he will reintroduce a bill to shield marijuana conviction records next session.

Montana regulators proposed changes to rules on the makeup of the Hemp Advisory Committee.

Michigan regulators published an advisory bulletin on medical cannabis business licensing and renewal fees.

Oklahoma regulators posted an overview of medical cannabis legislation that passed this session.

Vermont regulators will begin accepting applications for all marijuana manufacturing license tiers, as well as for wholesalers, on Friday.

Marijuana Moment is tracking more than 1,500 cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments.

Learn more about our marijuana bill tracker and become a supporter on Patreon to get access.


Denver, Colorado officials launched a marijuana social equity technical assistance program.


The United Nations Office on Drugs and Crime’s World Drug Report 2022 claims that marijuana legalization is leading to more frequent use of cannabis, including highly potent products.

The Spanish Congress’s Health and Consumer Affairs Committee approved medical cannabis legislation.

The UK’s secretary of state for health and social care responded to a lawmaker’s question about rescheduling psilocybin.

Russia banned several Canadian cannabis and drug policy reform activists from entering the country.

The attorney general of the Bahamas said the government intends to enact medical cannabis and hemp legislation.


A study demonstrated that “cannabidiol is a viable therapy to treat prostate cancer cells, in combination with silencing of RBBP6,” suggesting that “cannabidiol rather Cannabis sativa extract may play an important role in reducing cancer progression.”

A review of research on ketamine-assisted psychotherapy concluded that “it is apparent that combined treatments can, in specific circumstances, initiate and prolong clinically significant reductions in pain, anxiety, and depressive symptoms, while encouraging rapport and treatment engagement, and promoting abstinence in patients addicted to other substances.”


A poll of New Zealand adults found that 61 percent support decriminalizing drugs.

The National Association of Broadcasters cheered the advancement of a spending bill provisions to protect radio and TV stations that aid marijuana ads from being punished by the Federal Communications Commission.


The Flowr Corporation eliminated 40 percent of its workforce.

Jushi Holdings Inc.’s CEO purchased an additional 100,000 shares, bringing his total ownership of the company to 16.9 percent.


The trial of American basketball player Brittney Griner, who is being detained in Russia after allegedly being caught with cannabis vapes at an airport, will start on July 1.

Make sure to subscribe to get Marijuana Moment’s daily dispatch in your inbox.

Marijuana Moment is made possible with support from readers. If you rely on our cannabis advocacy journalism to stay informed, please consider a monthly Patreon pledge.

Source link

Medical Disclaimer:

The information provided in these blog posts is intended for general informational and educational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with any questions you may have regarding a medical condition. The use of any information provided in these blog posts is solely at your own risk. The authors and the website do not recommend or endorse any specific products, treatments, or procedures mentioned. Reliance on any information in these blog posts is solely at your own discretion.

Leave a Reply
You May Also Like